NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET FORECAST 2019-2028

NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET FORECAST 2019-2028

The North America extra corporeal membrane oxygenation (ECMO) system market is estimated to showcase a CAGR of 4.78%, during the forecast period, 2019-2028. The rising prevalence of cardiovascular diseases is the dominant factor propelling the market growth of the region. Canada and the United States are evaluated for assessing the North America extra corporeal membrane oxygenation (ECMO) system market growth. High blood pressure, obesity, type-2 diabetes, and poor dietary practices have contributed to the increasing cases of cardiovascular disease in the US.

NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET FORECAST 2019-2028

North America Extra Corporeal Membrane Oxygenation (ECMO) System Market by Modality (Veno-venous, Veno-arterial, Other Modalities) by Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (Ecpr)) and by Geography.

Request free sample

The North America extra corporeal membrane oxygenation (ECMO) system market is estimated to showcase a CAGR of 4.78%, during the forecast period, 2019-2028. The rising prevalence of cardiovascular diseases is the dominant factor propelling the market growth of the region.
North-America-Extra-Corporeal-Membrane-Oxygenation-System-Market

To know more about this report, request a free sample copy

Canada and the United States are evaluated for assessing the North America extra corporeal membrane oxygenation (ECMO) system market growth. High blood pressure, obesity, type-2 diabetes, and poor dietary practices have contributed to the increasing cases of cardiovascular disease in the US. It was the leading cause of death in 2016, according to the Center for Disease Control and Prevention CDC. Also, as per their data, almost 5.7 million adults die of heart failure every year. Coronary heart disease accounted for almost 13% of deaths in 2017.  The use of ECMO (extracorporeal membrane oxygenation) can potentially reduce in-hospital failure numbers. The CDC states that around 7.9% of the population in the US had asthma in 2017. The annual asthma cases have taken a toll on the economic burden of the country. The market under study has ample growth opportunities, given the high death rates of asthma and the rising investment in treating them.

OriGen Biomedical Inc is a small, private medical device manufacturer founded in 1997, with its headquarters in Austin, Texas. The products of the company include those that treat cancer, genetic conditions, respiratory distress, etc. The company finds its place in the surgical & medical instrument manufacturing industry. The product portfolio includes OriGen Reinforced Dual Lumen Cannula and FloPump 32 Centrifugal Pump.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • INCREASED USAGE OF ECMO TECHNOLOGY
      • TECHNOLOGICAL ADVANCEMENT
      • GROWING BURDEN OF CHRONIC DISORDERS
    •    KEY RESTRAINTS
      • LACK OF SPECIALIZED EXPERTISE
      • HIGH COST OF ECMO SYSTEM
      • SIDE EFFECTS RELATED TO THE ECMO SYSTEM
      • PRESENCE OF CONVENTIONAL TECHNIQUES
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY MODALITY
    • VENO-VENOUS
    • VENO-ARTERIAL
    • OTHER MODALITIES
  3. MARKET BY APPLICATION
    • RESPIRATORY
    • CARDIAC
    • EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
  4. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPANY PROFILES
    • ABBOTT LABORATORIES
    • ALUNG TECHNOLOGIES INC.
    • ELSIUS BIOMEDICAL INC
    • EUROSETS
    • GETINGE AB
    • LIVANOVA PLC
    • MEDTRONIC PLC
    • MICROPORT SCIENTIFIC CORPORATION
    • NIPRO CORPORATION
    • ORIGEN BIOMEDICAL INC
    • SPECTRUM MEDICAL
    • TERUMO MEDICAL CORPORATION
    • XENIOS AG (FRESENIUS SE & CO KGAA)

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM

TABLE 2: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 4: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: LIST OF CHRONIC DISEASES

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: KEY INVESTMENT INSIGHTS

FIGURE 6: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, IN 2019

FIGURE 7: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, IN 2019

FIGURE 11: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 (IN $ MILLION)

FIGURE 12: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 15: THE UNITED STATES EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 16: CANADA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY MODALITY
    • VENO-VENOUS
    • VENO-ARTERIAL
    • OTHER MODALITIES
  2. MARKET BY APPLICATION
    • RESPIRATORY
    • CARDIAC
    • EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now